EARNINGS AND TRADING: Corel loss widens; Christie sells Vennersys
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 10.50p on 09-01-2026 at 18:55:08 |
|---|---|
| Change | 0.50p 5% |
| Buy | 11.00p |
| Sell | 10.00p |
| Last Trade: | Unknown 700,000.00 at 10.50p |
| Day's Volume: | 1,821,641 |
| Last Close: | 10.50p |
| Open: | 10.00p |
| ISIN: | GB00BYV81293 |
| Day's Range | 10.00p - 10.50p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £112.12m |
| VWAP: | 10.30066p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 700,000 | 10.50p | OTC Trade |
17:06:28 - 09-Jan-26 |
| Buy* | 5,000 | 10.80p | Ordinary |
16:25:26 - 09-Jan-26 |
| Buy* | 2,000 | 10.80p | Ordinary |
15:36:53 - 09-Jan-26 |
| Buy* | 4,651 | 10.75p | Ordinary |
15:09:08 - 09-Jan-26 |
| Buy* | 1,010 | 10.75p | Ordinary |
14:59:17 - 09-Jan-26 |
| Buy* | 10,000 | 10.80p | Ordinary |
14:29:09 - 09-Jan-26 |
| Buy* | 30,000 | 10.4875p | Ordinary |
14:08:05 - 09-Jan-26 |
| Buy* | 30,000 | 10.4875p | Ordinary |
14:07:45 - 09-Jan-26 |
| Buy* | 381 | 10.50p | SI Trade |
14:06:02 - 09-Jan-26 |
| Buy* | 110 | 10.50p | SI Trade |
14:06:02 - 09-Jan-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Jan 2026 11:06 am | RNS | Block listing 6 Monthly Return |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 18th Dec 2025 7:13 am | RNS | Block Listing Application |
| 11th Dec 2025 7:00 am | RNS-R | Shield Wins Gold at Titan Branding Awards |
| 3rd Dec 2025 7:04 am | RNS | Amends Senior Secured Debt Financing |
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |